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Sialic acid in lipopolysaccharides (LPS) of mucosal pathogens is known to be an important virulence factor. Few
strains of Helicobacter pylori express sialyl-Lewis-X and we have reported that human and canine Helicobacter
bizzozeronii strains express sialyl-lactoseamine in their LPS. However, the role of sialyation of Helicobacter LPS in the
interaction with the host cells is still unknown. In this study H. bizzozeronii LPS is shown to activate the TLR2 in a
dose and strain dependent manner in the in vitro HEK-293 cells model expressing TLR2, but not the cells expressing
TLR4. These results indicate that TLR2 is the specific receptor for H. bizzozzeronii LPS, as previously described for H.
pylori. To further explore the role of sialylation of H. bizzozeronii LPS on TLR2 response, H. bizzozeronii Δhbs2 mutant
strains deficient in sialyltransferase activity were constructed by homologous recombination. LPS from H. bizzozeronii
Δhbs2 strains enhanced the NF-ĸB induction via TLR2 compared to the respective wild types, leading to the conclusion
that the sialylation of H. bizzozeronii LPS in wild-type strains may modulate host immune response.Introduction
In both humans and several animal species helicobacters
are recognised as an etiologic agent of chronic gastritis,
gastric ulcers and, in some cases, even gastric adenocar-
cinoma and MALT lymphoma [1,2]. Helicobacter spp.
are highly diverse, appear to have a host species-specific
tropism, the transmission occurs mainly vertically and
the colonisation generally persists throughout the life-
time of their hosts [1,2]. Several species have also developed
the ability to jump between different hosts [1,3]. Among
them, the gastric Helicobacter spp., belonging to the group
of H. heilmannii sensu lato (including H. bizzozeronii, H.
felis, H. suis and H. heilmannii sensu stricto), have zoonotic
potential and have been detected in 0.6-2% of human
gastritis [1,3].
After penetration of the mucous layer, gastric epithelial
cells provide the first point of contact between helico-
bacters and their hosts [4]. By recognizing diverse mi-
crobial products, Toll-like receptors (TLRs) expressed
on the surface of gastric epithelial cells play a key role in
mediating cell-signalling which results in the induction* Correspondence: mirko.rossi@helsinki.fi
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unless otherwise stated.of host defence stimulation [5]. Although all described
TLRs have the ability to activate the key transcription
factors NF-κB and AP-1, there are differences in the ul-
timate gene-expression profile that results from the acti-
vation of a specific TLR [6]. For example, it has been
described that TLR2 and TLR4 differentially activate hu-
man dendritic cells (DC) resulting in differences in cyto-
kine and chemokine gene transcription, suggesting that
TLR2 and TLR4 signalling is not equivalent [7]. TLR4
specifically recognizes Lipopolysaccharide (LPS) from
Gram negative bacteria [8]. TLR2 has a broader spectrum
of ligands including also forms of LPS that are structurally
different from those recognized by TLR4 [6,8]. In particu-
lar, it has been described that H. pylori LPS specifically
stimulate TLR2 and act as antagonist of TLR4 [6,9]. Very
little is known about the ability of non-H. pylori Helico-
bacter species LPS in modulating host-response, despite
the fact they express different LPS structures [10,11]. Ac-
tually, the human pathogen canine-adapted H. bizzozeronii
expresses phase variable sialyl-lactoseamine [11]: a feature
not detected in H. pylori which rarely express sialyl-Lewis
antigens on their LPS. Therefore, the aim of this paper
was to elucidate the interaction between H. bizzozeronii
LPS and human TLR as first stage in host-bacteriall. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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role of sialylated LPS in this interaction.
Material and methods
Cell lines
HEK-293 cells from InvivoGen (Toulouse, France) stably
transfected with human TLR-2 (HEK-Blue™-hTLR2), and
TLR4 (HEK-Blue™-hTLR4) and HEK-Blue™ Null1 cells
non-expressing either TLR2 or TLR4 were grown and
maintained according to the manufacturer’s guidelines.
Briefly, HEK-Blue™- cell lines were cultured in DMEM
(Life Technology, Carlsbad, CA, USA) containing 10%
Fetal Bovine Serum (FBS) supplemented with 50 U.mL−1
of penicillin and 50 μg.mL−1 of streptomycin (Life Tech-
nology), 100 μg.mL−1 of normocin (InvivoGen), and 1X
HEK-Blue™ selection (InvivoGen; selection for HEK-
Blue™-hTLR2 and HEK-Blue™-hTLR4) or 100 μg.mL−1
zeocin (InvivoGen; selection for HEK-Blue™ Null1).
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1.
Helicobacter strains were routinely grown on HP medium
(LabM Limited, Lancashire, UK) containing 5% bovine
blood and Skirrow selective supplement (Oxoid, Ltd.,
Cambridge, UK) at 37 °C in an incubator with microaerobic
atmosphere (Thermo Forma, Series II Water Jacketed Incu-
bator; Thermo Fisher Scientific, Waltham, MA, USA). For
LPS extraction Helicobacter strains were cultivated in Brain
Heart Infusion (BHI, BD, Becton, Dickinson and Co., NJ,
USA) containing 10% of FBS, Skirrow selective supplement
(Oxoid) and Vitox supplement (Oxoid) at 37 °C in a jar
with microaerobic atmosphere. Campylobacter jejuni wasTable 1 Bacterial strains used in this study (h: human
isolates; c: canine isolates).
Bacterial species Strain Reference or source
Helicobacter bizzozeronii CIII-1GEN (h) [12,13]
R53 (h) [14]
Storkis CCUG 35545T (c) [15]
14 CCUG 35546 (c) [15]
12a (c) [15]




Heydar Δ hsb2-M2 this study
Heydar Δ hsb2-M4 this study
CIII-1GEN Δ hsb2-M9 this study
CIII-1GEN Δ hsb2-M13 this study
Helicobacter pylori 26695 [16]
Campylobacter jejuni 81-176 [17]cultivated in Nutrient Agar (Oxoid) supplemented with 5%
of bovine blood.
H. bizzozeronii α2,3-sialyltransferase gene (hbs2) mutant
strains
In H. bizzozeronii strains CIII-1 (human isolate) and
Heydar (canine isolate), chromosomal inactivation of
α2,3-sialyltransferase gene (hbs2) was performed by allelic
exchange using the chloramphenicol resistance gene (cat),
as previously described [18]. The cat gene was introduced
in the same direction as the target gene using XbaI and
KpnI restriction sites. The resultant plasmid, pMRS3, was
constructed and amplified in E. coli TOPO10 and used as
a suicide plasmid in H. bizzozeronii. Mutants were ob-
tained by electroporation as described for H. felis [19].
After electroporation, the bacteria were left to recover on
HP agar plates for 48 h under microaerobic conditions as
described above. The mutant strains were selected on HP
agar plates supplemented with 10 mg.mL−1 of chloram-
phenicol (Sigma-Aldrich, St. Louis, MI, USA). The plates
were incubated for up to 10 days, and the site of recom-
bination was verified by PCR and sequencing.
LPS extraction and LPS SDS-PAGE profile
LPS was extracted from biomass obtained after 48 h of
incubation in BHI broth. Crude LPS was extracted by
using the hot phenol-water method, and subsequent
purification by enzymatic treatments (RNase A, DNase
II and proteinase K) as described previously [6]. LPS
were treated with Lysozyme to remove traces of peptido-
glycan contamination [6]. After the enzymatic treat-
ments, the LPS was precipitated at −20 °C overnight in
10 volumes of pure ethanol in presence of 0.03 M of so-
dium acetate and re-suspended in water and the concentra-
tion was then determined by purpald assay [20]. The LPS
obtained was essentially free of proteins and nucleic acids,
and it had an electrophoretic profile similar to that previ-
ously reported for the low-molecular-mass H. bizzozeronii
LPS [11]. LPS was treated overnight with 6.7 U.mL−1 of
neuraminidase from Clostridium perfringens (Sigma-
Aldrich) at pH 6. LPS neuraminidase treated and un-
treated samples were loaded on 15% TRIS-Glycine
SDS-PAGE (Biorad, Hercules, CA, US), run for 2 h and
50 min at constant 20 mA and then silver stained as previ-
ous described [11].
NF-ĸB stimulation using HEK-Blue™ system and IL-8
determination
HEK-Blue™ cell lines are engineered HEK293 cells stably
transfected with a vector expressing secreted embryonic
alkaline phosphatase reporter (SEAP) gene under the
control of an inducible NF-ĸB promoter. Therefore,
stimulation of TLRs will result in an amount of extracel-
lular SEAP in the supernatant that is proportional to the
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ĸB stimulation, 96-well plates were seeded with 5.0 × 104
cells/well of HEK-Blue™-hTLR2 or HEK-Blue™ Null1, or
2.5 × 104 cells/well of HEK-Blue™-hTLR4. After overnight
incubation, cells were treated for 24 h with different
concentrations of LPS extracted from H. bizzozzeronii
strains. SEAP was measured at OD620 after 1 h of incu-
bation at 37 °C, by the addition of 180 μL of QUANTI-
Blue™ (InvivoGen) to 20 μL of the HEK-Blue™ cells
supernatants [21]. For some experiments LPS was pre-
treated with 40 μg.ml−1 polymyxin B sulphate (PB;
Sigma-Aldrich) at 37 °C for 45 min. As positive control
for HEK-Blue™-hTLR2, HEK-Blue™-hTLR4 and HEK-Blue™
Null1, 100 ng.mL−1 of Pam2CSK4 (Invivogen), 5 ng.mL−1
of E. coli LPS (Sigma-Aldrich) and 50 ng/mL of
Polyinosinic-polycytidylic acid (Invivogen) were used,
respectively. After 24 h incubation, induced HEK-Blue™-
hTLR2 supernatant was collected and IL-8 expression
was determined by ELISA according to the manufac-
turer’s guidelines (DuoSet ELISA development system:
R&D systems). All experiments were done in triplicate.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
version 6 for Windows, (San Diego California USA). For
groups comparison one-way ANOVA followed by
Bonferroni post-test with a cut-off of 0.05 was selected,
while for pairwise comparison unpaired two-tailed t-test
was carried out. For trend analysis one-way ANOVA
was followed by the test for linear trend as implemented
in the software. Error bars in the graphs in all figures
were calculated as Standard Error of the Mean (SEM).
Results
To identify the TLR responsible for the recognition of H.
bizzozzeronii LPS, HEK-293 cells stably transfected with
human TLR-2 (HEK-Blue™-hTLR2), and TLR4 (HEK-
Blue™-hTLR4) and HEK-Blue™ Null1 cells non-expressing
either TLR2 or TLR4 were stimulated with 25 μg.mL−1 of
LPS extracted from several human and canine H. bizzoz-
zeronii strains. H. bizzozzeronii LPS showed to activate
only the HEK-Blue™-hTLR2 in a strain dependent manner
(Figure 1). The NF- ĸB induction in HEK-Blue™-hTLR4 or
HEK-Blue™ Null1 cells treated with H. bizzozeronii LPS
was not different from untreated cells (OD620, 0.108 ±
0.03). For further analysis, two H. bizzozeronii strains in-
ducing high (CIII-1GEN) and low (Heydar) NF- ĸB were se-
lected. NF- ĸB induction in HEK-Blue™-hTLR2 cells in
response to H. bizzozeronii CIII-1GEN and Heydar LPS
was found to be dose dependent (one-way ANOVA, test
for linear trend, p < 0.05; Figure 2A). To demonstrate that
the observed TLR2-mediated effects were LPS specific,
LPS was pre-incubated with the antibiotic polymyxin B
sulphate (PB), an inhibitor of the activating properties ofLPS [6]. Therefore, 12.5 μg.mL−1 of LPS from H. bizzoz-
zeronii CIII-1GEN and Heydar were pre-treated with
40 μg.mL−1 of PB at 37 °C for 45 min before infecting
the HEK-Blue™-hTLR2. A significant difference in the
NF-ĸB –inducing ability of LPS before and after treat-
ment was observed for both stains (unpaired two-tailed
t-test p < 0.05; Figure 2B), indicating that TLR2 activa-
tion was mediated by H. bizzozzeronii LPS. PB was able
to inhibit the TLR2 activation only partially. This is a
consequence of low extent of phosphorylation in the
lipid A of Helicobacter spp. LPS which is required for
binding PB, as previously described [6]. In order to
study the effect of sialylation of H. bizzozeronii LPS on
TLR2 response, H. bizzozeronii Δhbs2 mutant strains
deficient in sialyltransferase activity were created. The
LPS profile of CIII-1GEN wild type and Heydar wild type
showed low-molecular-weight LPS with a clear switch
of the band after neuraminidase treatment but no
switch was observed in the CIII-1GEN Δhbs2 and Heydar
Δhbs2 mutants as we expected (see Additional file 1).
HEK-Blue™-hTLR2 were incubated for 24 h with differ-
ent concentrations of LPS isolated from CIII-1GEN wild
type, Heydar wild type and corresponding Δhbs2 mu-
tant strains (Figure 3). H. bizzozeronii CIII-1GEN Δhbs2-
M9 and Heydar Δhbs2-M4 mutant strains enhanced sig-
nificantly the induction of NF-ĸB compared to wild type
strains (unpaired two-tailed t-test p < 0.05; Figure 3A).
To further explore IL-8–inducing activity of H. bizzo-
zeronii LPS, supernatants of HEK-Blue™-hTLR2 were
collected after 24 h of incubation with different concen-
trations of LPS isolated from CIII-1GEN wild type, Hey-
dar wild type and corresponding Δhbs2 mutant strains
and IL-8 expression was determined by DuoSet ELISA
Kit. The disruption of hbs2 in H. bizzozeronii signifi-
cantly enhanced the expression of IL-8 HEK-Blue™-
hTLR2 cells (unpaired two-tailed t-test p < 0.05;
Figure 3B). To verify if that increase of IL-8 expression
by HEK-Blue™-hTLR2 was a result of the mutation of
hbs2 and not due to a polar effect, and in the absence of
a protocol for the complementation, two independent
isogenic mutants were selected one from each H. bizzo-
zeronii strains: CIII-1GEN Δhbs2-M13 and Heydar
Δhbs2-M2. After inoculating HEK-Blue™-hTLR2 cells
with 12.5 μg.mL−1 of LPS we observed that both iso-
genic H. bizzozeronii CIII-1GEN Δhbs2-M13 and Heydar
Δhbs2-M2 mutants enhanced the expression of IL-8 by
2.4 and 3.0 fold, compared to the respective wild type
strain. Although we observed a lower increase of IL-8
expression compared to H. bizzozeronii CIII-1GEN
Δhbs2-M9 (5.4 fold) and Heydar Δhbs2-M4 (4.8 fold)
mutants, these results confirmed the role of core or O-
chain composition and particularly the presence of sialic
acid in the modulation of the host response through
TLR2 activation.
Figure 1 Differential human TLR2 activation by H. bizzozeronii LPS. HEK-Blue™-hTLR2 cells were incubated for 24 h with LPS (25 μg.mL−1)
extracted from different human (white bars) and canine (grey bars) strains, and NF-κB-induced SEAP activity was assessed using QUANTI-Blue™
and by reading the OD at 620 nm. The values were normalized by subtracting the average OD620 values of the untreated cells. The OD620 value
of the positive control Pam2CSK4 was 2.25 ± 0.12. Error bars show ± SEM.
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There have been conflicting findings in the literature
concerning the TLR responsible for the recognition of
Helicobacter LPS, as some authors have suggested that
Helicobacter LPS stimulate TLR4, whereas others pro-
posed a role for TLR2 [6,22]. Although we cannot com-
pletely exclude possible contaminations, the absence of
NF-ĸB induction in either HEK-Blue™-hTLR4 or HEK-
Blue™ Null1 cells, the suppression effect of PB on the
TLR2 activation and the dose-depend response of HEK-
Blue™-hTLR2 suggest that H. bizzozeronii LPS functionFigure 2 Human TLR2 response is mediated by H. bizzozzeronii LPS. (
manner. HEK-Blue™-hTLR2 cells were incubated for 24 h with different con
isolate Heydar (grey bars) H. bizzozzeronii strains. HEK-Blue™-hTLR2 response d
(B) Inhibitory effect of Polymyxin B in TLR2 activation by H. bizzozzeronii LPS. L
and the canine Heydar (grey bars) H. bizzozzeronii strains, were pre-incubated
incubated with LPS (with and without PB treatment) for 24 h. HEK-Blue™-hTLR
response was significantly different (p < 0.05) in both the strains. The values w
cells. The OD620 value of the positive control Pam2CSK4 was 2.25 ± 0.12. Erroras a classic TLR2 ligand, as described for H. pylori [6]
and for H. felis [22]. We observed a degree of variation
in the TLR2 mediated NF-ĸB –inducing ability of LPS
prepared from different strains of H. bizzozeronii. As
previously described, these differences could be the con-
sequence of variations in the degree of acylation and/or
phosphorylation of the LPS from different isolates [6].
However, MALDI-TOF analysis indicated that Lipid A
structures from both the selected H. bizzozeronii strains
CIII-1GEN (inducing high concentration of NF- ĸB) and
Heydar (inducing low concentration of NF- ĸB) wereA) H. bizzozeronii LPS activates human TLR2 in dose dependent
centrations of LPS from human isolate CIII-1GEN (white bars) and canine
ecrease significantly (test for linear trend; p < 0.05). Error bars show ± SEM.
PS (12.5 μg.mL−1) extracted from the human strain CIII-1GEN (white bars)
with PB (40 μg.mL−1) for 45 min at 37 °C. HEK-Blue™-hTLR2 cells were
2 response was inhibited in both strains after treatment with PB and the
ere normalized by subtracting the average OD620 values of the untreated
bars show ± SEM.
Figure 3 Desialylated LPS of H. bizzozeronii increases human TLR2 response. (A) NF-ĸB stimulation and (B) IL-8 expression by HEK-Blue™-
hTLR2 cells were determined after 24 h of incubation with different concentrations of LPS isolated from CIII-1GEN wild type (white bars), Heydar
wild type (grey bars) and respective Δhbs2 mutants (striped bars). The TLR2 response between wild type and mutants was significantly different
(*p < 0.05), respectively. Error bars show ± SEM.
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hydroxyoctadecanoic acid, n-octadecanoic acid, and 3-
hydroxyhexadecanoic acid are substituting at O- and N
positions (see Additional file 2). In addition, phos-
phoethanolamine was shown to be present in the Lipid
A of both H. bizzozzeronii strains and no extra phos-
phates were detected (data not shown). Therefore, in
agreement with previous studies [6,22], we hypothesized
that also differences in the core and O-chains of the LPS
from individual isolates could modulate the IL-8–indu-
cing activity of the lipid A component [22]. In fact, al-
though both H. bizzozeronii CIII-1GEN and Heydar
strains have a single copy of α2,3-sialyltransferase gene
(hbs2) and express sialic acid on their LPS, they shown
different reactivity with cholera toxin, indicating possibledifferent LPS structures [11]. Studies on C. jejuni have
shown that sialylation of lipooligosaccharides (LOS)
modulates the dendritic cells (DC) response via TLR4
[24]. In particular, the presence of sialic acid on the C.
jejuni LOS induced a stronger DC activation and subse-
quent B cell proliferation than did desialylated LOS by
increasing TLR4-mediated signalling [24]. These data to-
gether with the results from another study [25] indicate
that not only the lipid A structure but also the C. jejuni
LOS carbohydrate moiety modulates TLR4-mediated
host-response. Similarly, in the present study we showed
that TLR2-mediated NF-ĸB induction and resulting IL-8
expression in HEK293 was modulated by the H. bizzo-
zeronii LPS carbohydrate moiety and in particular by the
presence of sialic acid. However, differently to what is
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mediated induction of NF-kB.
It has been suggested that TLR2 on DCs plays an im-
portant role in immune tolerance [26]. However, it was
also showed that TLR2 on epithelial cells activates in-
flammatory mediators [6]. Thus, activation of TLR2, on
the one hand, increases the immune tolerance favouring
persistence of the bacterium in the stomach and, on the
other hand, increases epithelial inflammatory responses
resulting potentially in more severe gastritis [26]. How-
ever, Sun et al. observed enhanced gastric immunopa-
thology in H. pylori-infected TLR2-KO mice, indicating
that the impact of total TLR2 deficiency is greater on
immune cells than on epithelial cells [26]. Therefore, it
is tempting to speculate that the sialylation of H. bizzo-
zeronii LPS may increase inflammatory responses by de-
pressing the TLR2 response. However, further in vivo
studies are needed for elucidating the proinflammatory
effect of Helicobacter sialyl-LPS.
In conclusion, our study showed that the sialylation of
H. bizzozeronii LPS in wild-type strains may modulate
host immune response. Since we observed that the ex-
pression of sialylated LPS by H. bizzozeronii undergoes
phase and phenotypic variation [11], changes in the
stomach microenvironments due to diet, host-jump,
antimicrobial treatment [12], may select subpopulations
of H. bizzozeronii expressing or not sialylated LPS. These
events could lead to an imbalance in the relationship be-
tween H. bizzozeronii and his host, underpinning the de-
velopment of gastritis in both dogs and humans.
Additional files
Additional file 1: LPS profile of wild type and mutant H.
bizzozeronii CIII-1GEN and Heydar strains. LPS profile in 15% TRIS-Glycine
SDS-PAGE gel. H. bizzozzeronii strains CIII-1GEN wild type and Heydar wild
type showed low-molecular-weight LPS with a clear switch of the band after
neuraminidase treatment (*) but no switch was observed in the relative
Δhbs2 isogenic mutants.
Additional file 2: MALDI-TOF spectra of H. bizzozeronii CIII-1GEN wild
type and Heydar wild type LPS. (A) H. bizzozeronii CIII-1GEN. (B) H. bizzozeronii
Heydar.
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